The homograft aortic valve: A 29-year, 99.3% follow up of 1,022 valve replacements

Journal of Heart Valve Disease

Volumn 10, Issue 3, 2001, Pages 334-345

  O'Brien, M F ^a   Harrocks, S ^a   Stafford, E G ^a   Gardner, M A H ^a   Pohlner, P G ^a   Tesar, P J ^a   Stephens, F ^b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; AORTA GRAFT; AORTA ROOT; AORTA VALVE REPLACEMENT; ARTICLE; CHILD; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CRYOPRESERVATION; DEGENERATION; DISEASE CLASSIFICATION; ENDOCARDITIS; FEMALE; FOLLOW UP; GRAFT PRESERVATION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; BIOPROSTHESIS; CHILD; CHILD, PRESCHOOL; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; INFANT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; THROMBOEMBOLISM; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0035020759     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. O'Brien MF, Stafford EG, Gardner MA, Pohlner PG, McGiffin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987;94:812-823
2. O'Brien M, Stafford EG, Gardner M, et al. The viable cryopreserved allograft aortic valve. J Cardiac Surg 1987;1(Suppl.2):153-167
3. O'Brien MF, McGiffin DC, Stafford EG. Allograft aortic valve implantation: Techniques for all types of aortic valve and root pathology. Ann Thorac Surg 1989;48:600-609
4. O'Brien MF, McGiffin DC, Stafford EG, et al. Allograft aortic valve replacement: Long-term comparative clinical analysis of the viable cryopreserved and antibiotic 4-degrees C stored valves. J Cardiac Surg 1991;6(4 Suppl.):534-543
5. O'Brien MF, Stafford EG, Gardner MAH, et al. Allograft aortic valve replacement: Long-term follow-up. Ann Thorac Surg 1995;60:S65-S70
6. Langley SM, McGuirk SP, Chaudhry MA, Livesey SA, Ross JK, Monro JL. Twenty year follow-up of aortic valve replacement with antibiotic sterilised homografts in two hundred patients. Semin Thorac Cardiovasc Surg 1999:11:4(Suppl.1):28-34
7. Yacoub M, Rasmi NR, Sundt TM, et al. Fourteen year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:186-194
8. Lund O, Chandrasekaran V, Grocott-Mason R, et al. Primary aortic valve replacement with allografts over twenty-five years: Valve related and procedure related determinants of outcome. J Thorac Cardiovasc Surg 1999;117:77-91
9. Langley SM, Livesey SM, Tsang VT, et al. Long-term results of valve replacement using antibiotic sterilised homografts in the aortic position. Eur J Cardiothorac Surg 1996;10:1097-1106
10. Doty JR, Salazar JD, Liddicoat JR, Flores JH, Doty DB. Aortic valve replacement with cryopreserved aortic allograft: Ten year experience. J Thorac Cardiovasc Surg 1998;115:371-380
11. Rubay JE, Raphael D, Sluysmans T, et al. Aortic valve replacement with allograft/autograft: Subcoronary versus intraluminal cylinder or root. Ann Thorac Surg. 1995;60(2 Suppl.):S78-S82
12. Kirklin JW. Whither cardiac surgery in the next quarter century. In: Davila JC (ed). Second Henry Ford Hospital International Symposium on Cardiac Surgery. Appleton-Century-Crofts, New York; 1975:705-710
13. Watts LK, Duffy P, Field RB, Stafford EG, O'Brien MF. Establishment of a viable homograft cardiac valve bank: A rapid method of determining homograft viability. Ann Thorac Surg 1976:21:230
14. Gall K, Smith S, Willmette C, Wong M, O'Brien MF. Allograft heart valve sterilisation: A six year in depth analysis of a twenty-five year experience with low dose antibiotics. J Thorac Cardiovasc Surg 1995;110:680-687
15. Gall K, Smith S, Willmette C, O'Brien MF. Allograft heart valve viability: A quantitative assessment of the effects of valve processing on fibroblast viability and valve processing variables. Ann Thorac Surg 1998;65:1032-1038
16. O'Brien MF, Finney S, Stafford EG, et al. Root replacement for all allograft aortic valves: Preferred technique or too radical? Ann Thorac Surg 1995;60:S87-S89
17. O'Brien MF. Allograft aortic root replacement: Standardization and simplification of technique. Ann Thorac Surg 1995;60:S92-S94
18. Edmunds LH, Jr., Clark RE, Cohn LH, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1988;46:257-259
19. Bodnar E, Butchart EG, Bamford J, Besselaar AMPH, Grunkemeier GL, Frater RWM. Proposal for reporting thrombosis, embolism and bleeding after heart valve replacement. J Heart Valve Dis 1994;3:120-123
20. O'Brien MR An exceedingly low operative mortality given by stentless autologous, homologous and heterologous aortic valves for AVR. Semin Thorac Cardiovasc Surg (Suppl) 1999:11(4Suppl.1):12-17
21. Bodnar E, Matsuki O, Parker R, Ross DN. Viable and non-viable aortic homografts in the subcoronary position: A comparative study. Ann Thorac Surg 1989;46:799-805
22. Bodnar E, Parker R, Davies J, Robles A, Ross DN. Non-viable aortic homografts. In: Bodnar E (ed). Surgery for Heart valve Disease. ICR Publishers, London; 1990:494-506
23. Jamieson WRE, Burr LH, Mayagishima RT, Germann E, Anderson WN. Actuarial versus actual freedom from structural valve deterioration with the Carpentier-Edwards porcine bioprosthesis. Can J Cardiol 1999;15:973-978
24. Grunkemeier GL, Anderson RP, Miller DC, Starr A. Time related analysis of non fatal heart valve complications: Cumulative incidence (actual) versus Kaplan-Meier (actuarial). Circulation 1997;96(9Suppl.):1170-1175